A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Professor Stephen Caddick
VICE-PROVOST (ENTERPRISE AND LONDON)
T: +44 (0)20 3108 5072
UCL Enterprise is led by the Vice-Provost (Enterprise and London), Professor Stephen Caddick. The Office of the Vice-Provost (Enterprise) is responsible for delivering UCL’s Enterprise agenda with the greatest economic and societal impact. The Vice-Provosts are members of the Provost's senior management team.
“Enterprise is important to all
universities, but resonates particularly with UCL. From our inception we were
created as an enterprising institution, with a bold ambition to create a
University dedicated to the greatest good for the greatest number. There are outstanding opportunities for us to work with all
academic departments and divisions to help enrich the core academic mission of
teaching and research and to identify innovative ways of engagement with the wider
world. An enterprising community is one that is resourceful, creative, dynamic,
and bold – characteristics that we recognise as part of the fabric of UCL.”
Professor Stephen Caddick, Vice-Provost (Enterprise and London)
Professor Stephen Caddick was appointed as Vice-Provost (Enterprise) in 2010. He joined UCL in 2003 as Vernon Professor of Organic Chemistry and Chemical Biology. He was the founding director of the Centre for Chemical Biology, and Head of the Department of Chemistry. He maintains an active academic research career, has many external roles and is co-founder of Thiologics, a spin-out company dedicated to developing new biological therapeutics.